Qianjin Pharmaceutical (600479.SH): Dydrogesterone tablets and other products are expected to be selected for national drug centralized procurement.

Zhitong Finance APP news, Qianjin Pharmaceutical (600479.SH) announced that on July 31, 2026, the company and its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. participated in the bidding work organized by the National Organization for Drug Joint Procurement Office for the 12th batch of nationwide centralized drug procurement. The company and Qianjin Xiangjiang Pharmaceutical plan to have four products, including Dydrogesterone Tablets, selected in this centralized procurement.